• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

John M. Leonard - Articles and news items

Abbott logo
Biogen Idec logo

Biogen Idec and Abbott present positive data for Daclizumab HYP from Select Phase 2b trial at ECTRIMS/ACTRIMS

Industry news, News / 22 October 2011 / Biogen Idec

Biogen Idec and Abbott announced additional results from the SELECT Phase 2b trial…


Webinar: Understanding ISO Standards: ISO 14644-2:2015 Cleanroom MonitoringWATCH NOW
+ +